Steven A Greenberg

Steven A Greenberg, M.D., M.S. is a clinical neurologist at Brigham and Women’s Hospital, and Professor of Neurology at Harvard Medical School. He completed internship, neurology residency, and neuromuscular disease fellowship programs at the Massachusetts General Hospital and the University of California San Francisco, and was a National Library of Medicine Fellow in Medical Informatics at the Harvard/Children’s Hospital Informatics Program in Boston. His clinical and laboratory research focus involves translational medicine, inventing diagnostics including blood tests for dermatomyositis and inclusion body myositis, and therapeutics, including co-inventing a therapeutic monoclonal antibody for dermatomyositis currently in phase 2 studies. He has authored over 100 publications and served as Principal Investigator for multiple clinical trials. He is the founder of the non-profit research organization, the Inclusion Body Myositis Foundation, and the biotechnology company Abcuro, Inc., focused on modulating T and NK cells for applications in oncology and autoimmunity. Dr. Greenberg received an A.B. degree in Mathematics from Princeton University, an M.S. degree in Medical Informatics from MIT, and an M.D. degree from Harvard Medical School through the Harvard-MIT Health Science and Technology Program.